全球酵素免疫分析法市場

預計到 2030 年全球酵素免疫分析法市場規模將達 211 億美元

全球酵素免疫分析法市場規模預計在2024年為178億美元，預計到2030年將達到211億美元，2024年至2030年的複合年成長率為2.9%。試劑和套件是本報告分析的細分市場之一，預計其複合年成長率為2.7%，到分析期結束時規模將達到132億美元。分析儀器/設備細分市場在分析期間的複合年成長率預計為3.5%。

美國市場規模估計為 49 億美元，中國市場預期複合年成長率為 5.4%

美國酵素免疫分析法市場規模預計在2024年達到49億美元。作為世界第二大經濟體，中國市場規模預計到2030年將達到41億美元，在2024-2030年的分析期間內，複合年成長率為5.4%。其他值得關注的區域市場包括日本和加拿大，預計在分析期間內，這兩個市場的複合年成長率分別為1.1%和2.2%。在歐洲，預計德國市場的複合年成長率為1.6%。

全球酵素免疫分析法市場—主要趨勢與促進因素摘要

為什麼酵素免疫分析法（EIA）在診斷測試中變得越來越重要？

酵素免疫分析法(EIA) 已成為診斷檢測中的重要工具，可快速、靈敏且特異性檢測生物標記、病原體和抗體。該技術因其高通量能力以及檢測低濃度目標分子的能力，廣泛應用於醫學診斷、藥物研究和環境檢測。感染疾病、自體免疫疾病以及癌症和心血管疾病等慢性疾病的日益流行，推動了對基於 EIA 的診斷解決方案的需求。

檢測法設計技術的進步，例如酵素結合免疫吸附檢測法(ELISA)、化學冷光免疫檢測(CLIA) 和多重免疫檢測的開發，提高了靈敏度和特異性。向自動化和照護現場(POC) 的轉變進一步擴大了酶聯免疫吸附試驗 (EIA) 在臨床實驗室和家庭診斷中的應用。早期疾病檢測和個人化醫療的需求正在推動對能夠提供快速、高精度診斷結果的新型免疫檢測的研究。

技術創新如何提高酵素免疫分析法的效率？

酵素免疫分析法領域的最新創新提高了測定性能，縮短了傳輸時間，並增強了自動化能力。微流體技術的整合推動了微型化、高通量免疫測量平台的開發，在提高效率的同時降低了試劑消費量。此外，奈米技術的進步促進了能夠早期檢測疾病生物標記的超靈敏免疫測量的發展。

人工智慧 (AI) 和機器學習正被用於更準確地分析免疫檢測結果，減少人為錯誤，並提高診斷準確性。重組酶和人工抗體的使用透過降低交叉反應性並提高檢測特異性，提高了酶聯免疫吸附試驗 (EIA) 的可靠性。隨著對快速、經濟高效且可靠的診斷工具的需求不斷成長，酵素免疫分析法市場預計將持續發展，尤其是在傳染病檢查和癌症生物標記檢測領域。

推動酵素免疫分析法市場成長的關鍵因素有哪些？

酵素免疫分析法市場的成長受到多種因素的推動，例如感染疾病病率的上升、照護現場的普及以及免疫檢測技術的進步。對疾病早期檢測需求的日益成長以及生物標記發現研究的不斷拓展，推動了對高靈敏度和特異性酶聯免疫吸附試驗（EIA）的需求。此外，監管機構的核准和政府對診斷技術進步的資助也支持了市場的擴張。

家用和可攜式免疫檢測套件的興起，尤其是用於慢性病自我監測和傳染病檢查的試劑盒，進一步促進了市場的成長。製藥和生物技術產業也推動了藥物開發、治療監測和疫苗研究中對免疫測量的需求。隨著醫療保健提供者和研究人員持續投資於精準診斷，專注於提高診斷測試速度、準確性和自動化程度的技術創新預計將顯著推動酵素免疫分析法市場的發展。

部分

產品（試劑與套件、分析儀器/設備、軟體與服務）、檢體（血液、唾液、尿液、其他檢體）、應用（治療藥物監測、腫瘤學、心臟病學、循環系統、傳染病檢查、自體免疫疾病、其他）、最終用途（醫院、血庫、臨床實驗室、製藥與生物技術公司、學術研究中心、其他）

受訪公司範例

• Abbott Laboratories
• Arlington Scientific, Inc.
• Becton, Dickinson and Company
• Biobase Biodustry（Shandong）Co., Ltd.
• bioMerieux SA
• Bio-Rad Laboratories, Inc.
• Carolina Liquid Chemistries Corp.
• Charles River Laboratories
• Danaher Corporation（Beckman Coulter）
• DiaSorin SpA
• Diazyme Laboratories, Inc.
• F. Hoffmann-La Roche AG
• Hologic, Inc.
• Illumina, Inc.
• Ortho Clinical Diagnostics
• Qiagen NV
• QuidelOrtho Corporation
• Siemens Healthineers
• Sysmex Corporation
• Thermo Fisher Scientific, Inc.

人工智慧整合

全球產業分析師正在利用可操作的專家內容和人工智慧工具改變市場和競爭情報。

Global Industry Analysts 並未遵循典型的 LLM 或特定產業的 SLM查詢，而是建立了一個從全球專家收集的內容庫，其中包括影片錄影、部落格、搜尋引擎研究以及大量的公司、產品/服務和市場數據。

關稅影響係數

全球產業分析師根據公司總部所在國家、製造地、進出口狀況（成品和原始OEM）預測其競爭態勢的變化。這種複雜且多面向的市場動態預計將以多種方式影響競爭對手，包括銷貨成本成本 (COGS) 上升、盈利下降、供應鏈重組以及其他微觀和宏觀市場動態。

目錄

第1章調查方法

第2章執行摘要

• 市場概覽
• 主要企業
• 市場趨勢和促進因素
• 全球市場展望

第3章市場分析

• 美國
• 加拿大
• 日本
• 中國
• 歐洲
• 法國
• 德國
• 義大利
• 英國
• 西班牙
• 俄羅斯
• 其他歐洲國家
• 亞太地區
• 澳洲
• 印度
• 韓國
• 其他亞太地區
• 拉丁美洲
• 阿根廷
• 巴西
• 墨西哥
• 其他拉丁美洲
• 中東
• 伊朗
• 以色列
• 沙烏地阿拉伯
• 阿拉伯聯合大公國
• 其他中東地區
• 非洲

第4章 競賽

Global Enzyme Immunoassays Market to Reach US$21.1 Billion by 2030

The global market for Enzyme Immunoassays estimated at US$17.8 Billion in the year 2024, is expected to reach US$21.1 Billion by 2030, growing at a CAGR of 2.9% over the analysis period 2024-2030. Reagents & Kits, one of the segments analyzed in the report, is expected to record a 2.7% CAGR and reach US$13.2 Billion by the end of the analysis period. Growth in the Analyzers / Instruments segment is estimated at 3.5% CAGR over the analysis period.

The U.S. Market is Estimated at US$4.9 Billion While China is Forecast to Grow at 5.4% CAGR

The Enzyme Immunoassays market in the U.S. is estimated at US$4.9 Billion in the year 2024. China, the world's second largest economy, is forecast to reach a projected market size of US$4.1 Billion by the year 2030 trailing a CAGR of 5.4% over the analysis period 2024-2030. Among the other noteworthy geographic markets are Japan and Canada, each forecast to grow at a CAGR of 1.1% and 2.2% respectively over the analysis period. Within Europe, Germany is forecast to grow at approximately 1.6% CAGR.

Global Enzyme Immunoassay Market - Key Trends & Drivers Summarized

Why Is Enzyme Immunoassay (EIA) Gaining Importance in Diagnostic Testing?

Enzyme immunoassay (EIA) has become a critical tool in diagnostic testing, providing rapid, sensitive, and specific detection of biomarkers, pathogens, and antibodies. The technique is widely used in medical diagnostics, pharmaceutical research, and environmental testing due to its high-throughput capabilities and ability to detect even low concentrations of target molecules. The increasing prevalence of infectious diseases, autoimmune disorders, and chronic conditions such as cancer and cardiovascular diseases is driving the demand for EIA-based diagnostic solutions.

Technological advancements in assay design, such as the development of enzyme-linked immunosorbent assay (ELISA) variants, chemiluminescent immunoassays (CLIA), and multiplex immunoassays, have improved sensitivity and specificity. The shift toward automation and point-of-care (POC) testing is further expanding the adoption of EIA in clinical laboratories and home-based diagnostics. The demand for early disease detection and personalized medicine is fueling research into novel immunoassay formats that provide rapid and highly accurate diagnostic results.

How Are Innovations Enhancing the Efficiency of Enzyme Immunoassays?

Recent innovations in enzyme immunoassays are improving assay performance, reducing turnaround times, and increasing automation capabilities. The integration of microfluidic technology is enabling the development of miniaturized and high-throughput immunoassay platforms, which enhance efficiency while reducing reagent consumption. Additionally, advancements in nanotechnology are contributing to the development of ultra-sensitive immunoassays that can detect disease biomarkers at an early stage.

Artificial intelligence (AI) and machine learning are being leveraged to analyze immunoassay results more accurately, reducing human errors and improving diagnostic precision. The use of recombinant enzymes and engineered antibodies is enhancing the reliability of EIA by reducing cross-reactivity and increasing assay specificity. As demand for rapid, cost-effective, and reliable diagnostic tools grows, the enzyme immunoassay market is expected to witness continuous advancements, particularly in infectious disease testing and cancer biomarker detection.

What Are the Key Factors Driving Growth in the Enzyme Immunoassay Market?

The growth in the enzyme immunoassay market is driven by several factors, including the rising incidence of infectious diseases, increasing adoption of point-of-care diagnostic solutions, and advancements in immunoassay technology. The growing need for early disease detection and the expansion of research in biomarker discovery are fueling the demand for highly sensitive and specific EIA-based tests. Additionally, regulatory approvals and government funding for diagnostic advancements are supporting market expansion.

The rise of home-based and portable immunoassay kits, particularly for self-monitoring of chronic diseases and infectious disease testing, is further contributing to market growth. The pharmaceutical and biotechnology industries are also driving demand for immunoassays in drug development, therapeutic monitoring, and vaccine research. As healthcare providers and researchers continue to invest in precision diagnostics, the enzyme immunoassay market is expected to expand significantly, with innovations focused on improving speed, accuracy, and automation in diagnostic testing.

SCOPE OF STUDY:

The report analyzes the Enzyme Immunoassays market in terms of units by the following Segments, and Geographic Regions/Countries:

Segments:

Product (Reagents & Kits, Analyzers / Instruments, Software & Services); Specimen (Blood, Saliva, Urine, Other Specimens); Application (Therapeutic Drug Monitoring, Oncology, Cardiology, Endocrinology, Infectious Disease Testing, Autoimmune Diseases, Others); End-Use (Hospitals, Blood Banks, Clinical Laboratories, Pharma & Biotech Companies, Academic Research Centers, Others)

Geographic Regions/Countries:

World; United States; Canada; Japan; China; Europe (France; Germany; Italy; United Kingdom; Spain; Russia; and Rest of Europe); Asia-Pacific (Australia; India; South Korea; and Rest of Asia-Pacific); Latin America (Argentina; Brazil; Mexico; and Rest of Latin America); Middle East (Iran; Israel; Saudi Arabia; United Arab Emirates; and Rest of Middle East); and Africa.

Select Competitors (Total 34 Featured) -

• Abbott Laboratories
• Arlington Scientific, Inc.
• Becton, Dickinson and Company
• Biobase Biodustry (Shandong) Co., Ltd.
• bioMerieux SA
• Bio-Rad Laboratories, Inc.
• Carolina Liquid Chemistries Corp.
• Charles River Laboratories
• Danaher Corporation (Beckman Coulter)
• DiaSorin S.p.A.
• Diazyme Laboratories, Inc.
• F. Hoffmann-La Roche AG
• Hologic, Inc.
• Illumina, Inc.
• Ortho Clinical Diagnostics
• Qiagen N.V.
• QuidelOrtho Corporation
• Siemens Healthineers
• Sysmex Corporation
• Thermo Fisher Scientific, Inc.

AI INTEGRATIONS

We're transforming market and competitive intelligence with validated expert content and AI tools.

Instead of following the general norm of querying LLMs and Industry-specific SLMs, we built repositories of content curated from domain experts worldwide including video transcripts, blogs, search engines research, and massive amounts of enterprise, product/service, and market data.

TARIFF IMPACT FACTOR

Our new release incorporates impact of tariffs on geographical markets as we predict a shift in competitiveness of companies based on HQ country, manufacturing base, exports and imports (finished goods and OEM). This intricate and multifaceted market reality will impact competitors by increasing the Cost of Goods Sold (COGS), reducing profitability, reconfiguring supply chains, amongst other micro and macro market dynamics.

TABLE OF CONTENTS

I. METHODOLOGY

II. EXECUTIVE SUMMARY

• 1. MARKET OVERVIEW
  • Influencer Market Insights
  • Tariff Impact on Global Supply Chain Patterns
  • Enzyme Immunoassays - Global Key Competitors Percentage Market Share in 2025 (E)
  • Competitive Market Presence - Strong/Active/Niche/Trivial for Players Worldwide in 2025 (E)
• 2. FOCUS ON SELECT PLAYERS
• 3. MARKET TRENDS & DRIVERS
  • Rising Prevalence of Chronic and Infectious Diseases Spurs Demand for Enzyme Immunoassay Testing
  • Technological Advancements in Microfluidics and Lab-on-a-Chip Platforms Drive Innovation in EIA
  • Growing Adoption of Point-of-Care Testing Expands Addressable Market for Enzyme Immunoassays
  • Increasing Focus on Personalized Medicine Strengthens Business Case for Highly Specific EIA Kits
  • Surge in Biopharmaceutical R&D Activities Accelerates Demand for High-Throughput EIA Solutions
  • Advancements in Multiplexing Capabilities Propel Growth of EIA in Complex Diagnostic Applications
  • Integration of Artificial Intelligence and Data Analytics Enhances Diagnostic Accuracy of EIAs
  • Regulatory Push for Standardized and Quality-Assured Diagnostics Drives Adoption of Validated EIA Kits
  • Expansion of Public Health Screening Programs Generates Sustained Demand for EIA-Based Assays
  • Growing Investments in Veterinary Diagnostics Throws the Spotlight on Animal-Specific EIA Tests
  • Rising Trend Toward Home-Based and Self-Testing Kits Opens Up New Growth Avenues for EIAs
  • Greater Awareness and Early Detection Initiatives Fuel Market Penetration in Developing Regions
• 4. GLOBAL MARKET PERSPECTIVE
  • TABLE 1: World Enzyme Immunoassays Market Analysis of Annual Sales in US$ Million for Years 2015 through 2030
  • TABLE 2: World Recent Past, Current & Future Analysis for Enzyme Immunoassays by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
  • TABLE 3: World Historic Review for Enzyme Immunoassays by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 4: World 15-Year Perspective for Enzyme Immunoassays by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets for Years 2015, 2025 & 2030
  • TABLE 5: World Recent Past, Current & Future Analysis for Reagents & Kits by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
  • TABLE 6: World Historic Review for Reagents & Kits by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 7: World 15-Year Perspective for Reagents & Kits by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2015, 2025 & 2030
  • TABLE 8: World Recent Past, Current & Future Analysis for Analyzers / Instruments by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
  • TABLE 9: World Historic Review for Analyzers / Instruments by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 10: World 15-Year Perspective for Analyzers / Instruments by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2015, 2025 & 2030
  • TABLE 11: World Recent Past, Current & Future Analysis for Software & Services by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
  • TABLE 12: World Historic Review for Software & Services by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 13: World 15-Year Perspective for Software & Services by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2015, 2025 & 2030
  • TABLE 14: World Recent Past, Current & Future Analysis for Cardiology by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
  • TABLE 15: World Historic Review for Cardiology by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 16: World 15-Year Perspective for Cardiology by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2015, 2025 & 2030
  • TABLE 17: World Recent Past, Current & Future Analysis for Endocrinology by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
  • TABLE 18: World Historic Review for Endocrinology by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 19: World 15-Year Perspective for Endocrinology by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2015, 2025 & 2030
  • TABLE 20: World Recent Past, Current & Future Analysis for Infectious Disease Testing by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
  • TABLE 21: World Historic Review for Infectious Disease Testing by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 22: World 15-Year Perspective for Infectious Disease Testing by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2015, 2025 & 2030
  • TABLE 23: World Recent Past, Current & Future Analysis for Autoimmune Diseases by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
  • TABLE 24: World Historic Review for Autoimmune Diseases by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 25: World 15-Year Perspective for Autoimmune Diseases by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2015, 2025 & 2030
  • TABLE 26: World Recent Past, Current & Future Analysis for Other Applications by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
  • TABLE 27: World Historic Review for Other Applications by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 28: World 15-Year Perspective for Other Applications by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2015, 2025 & 2030
  • TABLE 29: World Recent Past, Current & Future Analysis for Therapeutic Drug Monitoring by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
  • TABLE 30: World Historic Review for Therapeutic Drug Monitoring by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 31: World 15-Year Perspective for Therapeutic Drug Monitoring by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2015, 2025 & 2030
  • TABLE 32: World Recent Past, Current & Future Analysis for Oncology by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
  • TABLE 33: World Historic Review for Oncology by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 34: World 15-Year Perspective for Oncology by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2015, 2025 & 2030
  • TABLE 35: World Recent Past, Current & Future Analysis for Hospitals by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
  • TABLE 36: World Historic Review for Hospitals by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 37: World 15-Year Perspective for Hospitals by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2015, 2025 & 2030
  • TABLE 38: World Recent Past, Current & Future Analysis for Blood Banks by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
  • TABLE 39: World Historic Review for Blood Banks by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 40: World 15-Year Perspective for Blood Banks by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2015, 2025 & 2030
  • TABLE 41: World Recent Past, Current & Future Analysis for Clinical Laboratories by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
  • TABLE 42: World Historic Review for Clinical Laboratories by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 43: World 15-Year Perspective for Clinical Laboratories by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2015, 2025 & 2030
  • TABLE 44: World Recent Past, Current & Future Analysis for Pharma & Biotech Companies by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
  • TABLE 45: World Historic Review for Pharma & Biotech Companies by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 46: World 15-Year Perspective for Pharma & Biotech Companies by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2015, 2025 & 2030
  • TABLE 47: World Recent Past, Current & Future Analysis for Academic Research Centers by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
  • TABLE 48: World Historic Review for Academic Research Centers by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 49: World 15-Year Perspective for Academic Research Centers by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2015, 2025 & 2030
  • TABLE 50: World Recent Past, Current & Future Analysis for Other End-Uses by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
  • TABLE 51: World Historic Review for Other End-Uses by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 52: World 15-Year Perspective for Other End-Uses by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2015, 2025 & 2030
  • TABLE 53: World Recent Past, Current & Future Analysis for Blood by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
  • TABLE 54: World Historic Review for Blood by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 55: World 15-Year Perspective for Blood by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2015, 2025 & 2030
  • TABLE 56: World Recent Past, Current & Future Analysis for Saliva by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
  • TABLE 57: World Historic Review for Saliva by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 58: World 15-Year Perspective for Saliva by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2015, 2025 & 2030
  • TABLE 59: World Recent Past, Current & Future Analysis for Urine by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
  • TABLE 60: World Historic Review for Urine by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 61: World 15-Year Perspective for Urine by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2015, 2025 & 2030
  • TABLE 62: World Recent Past, Current & Future Analysis for Other Specimens by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
  • TABLE 63: World Historic Review for Other Specimens by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 64: World 15-Year Perspective for Other Specimens by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2015, 2025 & 2030

III. MARKET ANALYSIS

• UNITED STATES
  • Enzyme Immunoassays Market Presence - Strong/Active/Niche/Trivial - Key Competitors in the United States for 2025 (E)
  • TABLE 65: USA Recent Past, Current & Future Analysis for Enzyme Immunoassays by Product - Reagents & Kits, Analyzers / Instruments and Software & Services - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 66: USA Historic Review for Enzyme Immunoassays by Product - Reagents & Kits, Analyzers / Instruments and Software & Services Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 67: USA 15-Year Perspective for Enzyme Immunoassays by Product - Percentage Breakdown of Value Sales for Reagents & Kits, Analyzers / Instruments and Software & Services for the Years 2015, 2025 & 2030
  • TABLE 68: USA Recent Past, Current & Future Analysis for Enzyme Immunoassays by Application - Cardiology, Endocrinology, Infectious Disease Testing, Autoimmune Diseases, Other Applications, Therapeutic Drug Monitoring and Oncology - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 69: USA Historic Review for Enzyme Immunoassays by Application - Cardiology, Endocrinology, Infectious Disease Testing, Autoimmune Diseases, Other Applications, Therapeutic Drug Monitoring and Oncology Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 70: USA 15-Year Perspective for Enzyme Immunoassays by Application - Percentage Breakdown of Value Sales for Cardiology, Endocrinology, Infectious Disease Testing, Autoimmune Diseases, Other Applications, Therapeutic Drug Monitoring and Oncology for the Years 2015, 2025 & 2030
  • TABLE 71: USA Recent Past, Current & Future Analysis for Enzyme Immunoassays by End-Use - Hospitals, Blood Banks, Clinical Laboratories, Pharma & Biotech Companies, Academic Research Centers and Other End-Uses - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 72: USA Historic Review for Enzyme Immunoassays by End-Use - Hospitals, Blood Banks, Clinical Laboratories, Pharma & Biotech Companies, Academic Research Centers and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 73: USA 15-Year Perspective for Enzyme Immunoassays by End-Use - Percentage Breakdown of Value Sales for Hospitals, Blood Banks, Clinical Laboratories, Pharma & Biotech Companies, Academic Research Centers and Other End-Uses for the Years 2015, 2025 & 2030
  • TABLE 74: USA Recent Past, Current & Future Analysis for Enzyme Immunoassays by Specimen - Blood, Saliva, Urine and Other Specimens - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 75: USA Historic Review for Enzyme Immunoassays by Specimen - Blood, Saliva, Urine and Other Specimens Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 76: USA 15-Year Perspective for Enzyme Immunoassays by Specimen - Percentage Breakdown of Value Sales for Blood, Saliva, Urine and Other Specimens for the Years 2015, 2025 & 2030
• CANADA
  • TABLE 77: Canada Recent Past, Current & Future Analysis for Enzyme Immunoassays by Product - Reagents & Kits, Analyzers / Instruments and Software & Services - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 78: Canada Historic Review for Enzyme Immunoassays by Product - Reagents & Kits, Analyzers / Instruments and Software & Services Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 79: Canada 15-Year Perspective for Enzyme Immunoassays by Product - Percentage Breakdown of Value Sales for Reagents & Kits, Analyzers / Instruments and Software & Services for the Years 2015, 2025 & 2030
  • TABLE 80: Canada Recent Past, Current & Future Analysis for Enzyme Immunoassays by Application - Cardiology, Endocrinology, Infectious Disease Testing, Autoimmune Diseases, Other Applications, Therapeutic Drug Monitoring and Oncology - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 81: Canada Historic Review for Enzyme Immunoassays by Application - Cardiology, Endocrinology, Infectious Disease Testing, Autoimmune Diseases, Other Applications, Therapeutic Drug Monitoring and Oncology Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 82: Canada 15-Year Perspective for Enzyme Immunoassays by Application - Percentage Breakdown of Value Sales for Cardiology, Endocrinology, Infectious Disease Testing, Autoimmune Diseases, Other Applications, Therapeutic Drug Monitoring and Oncology for the Years 2015, 2025 & 2030
  • TABLE 83: Canada Recent Past, Current & Future Analysis for Enzyme Immunoassays by End-Use - Hospitals, Blood Banks, Clinical Laboratories, Pharma & Biotech Companies, Academic Research Centers and Other End-Uses - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 84: Canada Historic Review for Enzyme Immunoassays by End-Use - Hospitals, Blood Banks, Clinical Laboratories, Pharma & Biotech Companies, Academic Research Centers and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 85: Canada 15-Year Perspective for Enzyme Immunoassays by End-Use - Percentage Breakdown of Value Sales for Hospitals, Blood Banks, Clinical Laboratories, Pharma & Biotech Companies, Academic Research Centers and Other End-Uses for the Years 2015, 2025 & 2030
  • TABLE 86: Canada Recent Past, Current & Future Analysis for Enzyme Immunoassays by Specimen - Blood, Saliva, Urine and Other Specimens - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 87: Canada Historic Review for Enzyme Immunoassays by Specimen - Blood, Saliva, Urine and Other Specimens Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 88: Canada 15-Year Perspective for Enzyme Immunoassays by Specimen - Percentage Breakdown of Value Sales for Blood, Saliva, Urine and Other Specimens for the Years 2015, 2025 & 2030
• JAPAN
  • Enzyme Immunoassays Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Japan for 2025 (E)
  • TABLE 89: Japan Recent Past, Current & Future Analysis for Enzyme Immunoassays by Product - Reagents & Kits, Analyzers / Instruments and Software & Services - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 90: Japan Historic Review for Enzyme Immunoassays by Product - Reagents & Kits, Analyzers / Instruments and Software & Services Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 91: Japan 15-Year Perspective for Enzyme Immunoassays by Product - Percentage Breakdown of Value Sales for Reagents & Kits, Analyzers / Instruments and Software & Services for the Years 2015, 2025 & 2030
  • TABLE 92: Japan Recent Past, Current & Future Analysis for Enzyme Immunoassays by Application - Cardiology, Endocrinology, Infectious Disease Testing, Autoimmune Diseases, Other Applications, Therapeutic Drug Monitoring and Oncology - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 93: Japan Historic Review for Enzyme Immunoassays by Application - Cardiology, Endocrinology, Infectious Disease Testing, Autoimmune Diseases, Other Applications, Therapeutic Drug Monitoring and Oncology Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 94: Japan 15-Year Perspective for Enzyme Immunoassays by Application - Percentage Breakdown of Value Sales for Cardiology, Endocrinology, Infectious Disease Testing, Autoimmune Diseases, Other Applications, Therapeutic Drug Monitoring and Oncology for the Years 2015, 2025 & 2030
  • TABLE 95: Japan Recent Past, Current & Future Analysis for Enzyme Immunoassays by End-Use - Hospitals, Blood Banks, Clinical Laboratories, Pharma & Biotech Companies, Academic Research Centers and Other End-Uses - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 96: Japan Historic Review for Enzyme Immunoassays by End-Use - Hospitals, Blood Banks, Clinical Laboratories, Pharma & Biotech Companies, Academic Research Centers and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 97: Japan 15-Year Perspective for Enzyme Immunoassays by End-Use - Percentage Breakdown of Value Sales for Hospitals, Blood Banks, Clinical Laboratories, Pharma & Biotech Companies, Academic Research Centers and Other End-Uses for the Years 2015, 2025 & 2030
  • TABLE 98: Japan Recent Past, Current & Future Analysis for Enzyme Immunoassays by Specimen - Blood, Saliva, Urine and Other Specimens - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 99: Japan Historic Review for Enzyme Immunoassays by Specimen - Blood, Saliva, Urine and Other Specimens Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 100: Japan 15-Year Perspective for Enzyme Immunoassays by Specimen - Percentage Breakdown of Value Sales for Blood, Saliva, Urine and Other Specimens for the Years 2015, 2025 & 2030
• CHINA
  • Enzyme Immunoassays Market Presence - Strong/Active/Niche/Trivial - Key Competitors in China for 2025 (E)
  • TABLE 101: China Recent Past, Current & Future Analysis for Enzyme Immunoassays by Product - Reagents & Kits, Analyzers / Instruments and Software & Services - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 102: China Historic Review for Enzyme Immunoassays by Product - Reagents & Kits, Analyzers / Instruments and Software & Services Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 103: China 15-Year Perspective for Enzyme Immunoassays by Product - Percentage Breakdown of Value Sales for Reagents & Kits, Analyzers / Instruments and Software & Services for the Years 2015, 2025 & 2030
  • TABLE 104: China Recent Past, Current & Future Analysis for Enzyme Immunoassays by Application - Cardiology, Endocrinology, Infectious Disease Testing, Autoimmune Diseases, Other Applications, Therapeutic Drug Monitoring and Oncology - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 105: China Historic Review for Enzyme Immunoassays by Application - Cardiology, Endocrinology, Infectious Disease Testing, Autoimmune Diseases, Other Applications, Therapeutic Drug Monitoring and Oncology Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 106: China 15-Year Perspective for Enzyme Immunoassays by Application - Percentage Breakdown of Value Sales for Cardiology, Endocrinology, Infectious Disease Testing, Autoimmune Diseases, Other Applications, Therapeutic Drug Monitoring and Oncology for the Years 2015, 2025 & 2030
  • TABLE 107: China Recent Past, Current & Future Analysis for Enzyme Immunoassays by End-Use - Hospitals, Blood Banks, Clinical Laboratories, Pharma & Biotech Companies, Academic Research Centers and Other End-Uses - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 108: China Historic Review for Enzyme Immunoassays by End-Use - Hospitals, Blood Banks, Clinical Laboratories, Pharma & Biotech Companies, Academic Research Centers and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 109: China 15-Year Perspective for Enzyme Immunoassays by End-Use - Percentage Breakdown of Value Sales for Hospitals, Blood Banks, Clinical Laboratories, Pharma & Biotech Companies, Academic Research Centers and Other End-Uses for the Years 2015, 2025 & 2030
  • TABLE 110: China Recent Past, Current & Future Analysis for Enzyme Immunoassays by Specimen - Blood, Saliva, Urine and Other Specimens - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 111: China Historic Review for Enzyme Immunoassays by Specimen - Blood, Saliva, Urine and Other Specimens Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 112: China 15-Year Perspective for Enzyme Immunoassays by Specimen - Percentage Breakdown of Value Sales for Blood, Saliva, Urine and Other Specimens for the Years 2015, 2025 & 2030
• EUROPE
  • Enzyme Immunoassays Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Europe for 2025 (E)
  • TABLE 113: Europe Recent Past, Current & Future Analysis for Enzyme Immunoassays by Geographic Region - France, Germany, Italy, UK, Spain, Russia and Rest of Europe Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
  • TABLE 114: Europe Historic Review for Enzyme Immunoassays by Geographic Region - France, Germany, Italy, UK, Spain, Russia and Rest of Europe Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 115: Europe 15-Year Perspective for Enzyme Immunoassays by Geographic Region - Percentage Breakdown of Value Sales for France, Germany, Italy, UK, Spain, Russia and Rest of Europe Markets for Years 2015, 2025 & 2030
  • TABLE 116: Europe Recent Past, Current & Future Analysis for Enzyme Immunoassays by Product - Reagents & Kits, Analyzers / Instruments and Software & Services - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 117: Europe Historic Review for Enzyme Immunoassays by Product - Reagents & Kits, Analyzers / Instruments and Software & Services Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 118: Europe 15-Year Perspective for Enzyme Immunoassays by Product - Percentage Breakdown of Value Sales for Reagents & Kits, Analyzers / Instruments and Software & Services for the Years 2015, 2025 & 2030
  • TABLE 119: Europe Recent Past, Current & Future Analysis for Enzyme Immunoassays by Application - Cardiology, Endocrinology, Infectious Disease Testing, Autoimmune Diseases, Other Applications, Therapeutic Drug Monitoring and Oncology - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 120: Europe Historic Review for Enzyme Immunoassays by Application - Cardiology, Endocrinology, Infectious Disease Testing, Autoimmune Diseases, Other Applications, Therapeutic Drug Monitoring and Oncology Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 121: Europe 15-Year Perspective for Enzyme Immunoassays by Application - Percentage Breakdown of Value Sales for Cardiology, Endocrinology, Infectious Disease Testing, Autoimmune Diseases, Other Applications, Therapeutic Drug Monitoring and Oncology for the Years 2015, 2025 & 2030
  • TABLE 122: Europe Recent Past, Current & Future Analysis for Enzyme Immunoassays by End-Use - Hospitals, Blood Banks, Clinical Laboratories, Pharma & Biotech Companies, Academic Research Centers and Other End-Uses - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 123: Europe Historic Review for Enzyme Immunoassays by End-Use - Hospitals, Blood Banks, Clinical Laboratories, Pharma & Biotech Companies, Academic Research Centers and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 124: Europe 15-Year Perspective for Enzyme Immunoassays by End-Use - Percentage Breakdown of Value Sales for Hospitals, Blood Banks, Clinical Laboratories, Pharma & Biotech Companies, Academic Research Centers and Other End-Uses for the Years 2015, 2025 & 2030
  • TABLE 125: Europe Recent Past, Current & Future Analysis for Enzyme Immunoassays by Specimen - Blood, Saliva, Urine and Other Specimens - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 126: Europe Historic Review for Enzyme Immunoassays by Specimen - Blood, Saliva, Urine and Other Specimens Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 127: Europe 15-Year Perspective for Enzyme Immunoassays by Specimen - Percentage Breakdown of Value Sales for Blood, Saliva, Urine and Other Specimens for the Years 2015, 2025 & 2030
• FRANCE
  • Enzyme Immunoassays Market Presence - Strong/Active/Niche/Trivial - Key Competitors in France for 2025 (E)
  • TABLE 128: France Recent Past, Current & Future Analysis for Enzyme Immunoassays by Product - Reagents & Kits, Analyzers / Instruments and Software & Services - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 129: France Historic Review for Enzyme Immunoassays by Product - Reagents & Kits, Analyzers / Instruments and Software & Services Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 130: France 15-Year Perspective for Enzyme Immunoassays by Product - Percentage Breakdown of Value Sales for Reagents & Kits, Analyzers / Instruments and Software & Services for the Years 2015, 2025 & 2030
  • TABLE 131: France Recent Past, Current & Future Analysis for Enzyme Immunoassays by Application - Cardiology, Endocrinology, Infectious Disease Testing, Autoimmune Diseases, Other Applications, Therapeutic Drug Monitoring and Oncology - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 132: France Historic Review for Enzyme Immunoassays by Application - Cardiology, Endocrinology, Infectious Disease Testing, Autoimmune Diseases, Other Applications, Therapeutic Drug Monitoring and Oncology Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 133: France 15-Year Perspective for Enzyme Immunoassays by Application - Percentage Breakdown of Value Sales for Cardiology, Endocrinology, Infectious Disease Testing, Autoimmune Diseases, Other Applications, Therapeutic Drug Monitoring and Oncology for the Years 2015, 2025 & 2030
  • TABLE 134: France Recent Past, Current & Future Analysis for Enzyme Immunoassays by End-Use - Hospitals, Blood Banks, Clinical Laboratories, Pharma & Biotech Companies, Academic Research Centers and Other End-Uses - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 135: France Historic Review for Enzyme Immunoassays by End-Use - Hospitals, Blood Banks, Clinical Laboratories, Pharma & Biotech Companies, Academic Research Centers and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 136: France 15-Year Perspective for Enzyme Immunoassays by End-Use - Percentage Breakdown of Value Sales for Hospitals, Blood Banks, Clinical Laboratories, Pharma & Biotech Companies, Academic Research Centers and Other End-Uses for the Years 2015, 2025 & 2030
  • TABLE 137: France Recent Past, Current & Future Analysis for Enzyme Immunoassays by Specimen - Blood, Saliva, Urine and Other Specimens - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 138: France Historic Review for Enzyme Immunoassays by Specimen - Blood, Saliva, Urine and Other Specimens Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 139: France 15-Year Perspective for Enzyme Immunoassays by Specimen - Percentage Breakdown of Value Sales for Blood, Saliva, Urine and Other Specimens for the Years 2015, 2025 & 2030
• GERMANY
  • Enzyme Immunoassays Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Germany for 2025 (E)
  • TABLE 140: Germany Recent Past, Current & Future Analysis for Enzyme Immunoassays by Product - Reagents & Kits, Analyzers / Instruments and Software & Services - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 141: Germany Historic Review for Enzyme Immunoassays by Product - Reagents & Kits, Analyzers / Instruments and Software & Services Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 142: Germany 15-Year Perspective for Enzyme Immunoassays by Product - Percentage Breakdown of Value Sales for Reagents & Kits, Analyzers / Instruments and Software & Services for the Years 2015, 2025 & 2030
  • TABLE 143: Germany Recent Past, Current & Future Analysis for Enzyme Immunoassays by Application - Cardiology, Endocrinology, Infectious Disease Testing, Autoimmune Diseases, Other Applications, Therapeutic Drug Monitoring and Oncology - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 144: Germany Historic Review for Enzyme Immunoassays by Application - Cardiology, Endocrinology, Infectious Disease Testing, Autoimmune Diseases, Other Applications, Therapeutic Drug Monitoring and Oncology Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 145: Germany 15-Year Perspective for Enzyme Immunoassays by Application - Percentage Breakdown of Value Sales for Cardiology, Endocrinology, Infectious Disease Testing, Autoimmune Diseases, Other Applications, Therapeutic Drug Monitoring and Oncology for the Years 2015, 2025 & 2030
  • TABLE 146: Germany Recent Past, Current & Future Analysis for Enzyme Immunoassays by End-Use - Hospitals, Blood Banks, Clinical Laboratories, Pharma & Biotech Companies, Academic Research Centers and Other End-Uses - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 147: Germany Historic Review for Enzyme Immunoassays by End-Use - Hospitals, Blood Banks, Clinical Laboratories, Pharma & Biotech Companies, Academic Research Centers and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 148: Germany 15-Year Perspective for Enzyme Immunoassays by End-Use - Percentage Breakdown of Value Sales for Hospitals, Blood Banks, Clinical Laboratories, Pharma & Biotech Companies, Academic Research Centers and Other End-Uses for the Years 2015, 2025 & 2030
  • TABLE 149: Germany Recent Past, Current & Future Analysis for Enzyme Immunoassays by Specimen - Blood, Saliva, Urine and Other Specimens - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 150: Germany Historic Review for Enzyme Immunoassays by Specimen - Blood, Saliva, Urine and Other Specimens Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 151: Germany 15-Year Perspective for Enzyme Immunoassays by Specimen - Percentage Breakdown of Value Sales for Blood, Saliva, Urine and Other Specimens for the Years 2015, 2025 & 2030
• ITALY
  • TABLE 152: Italy Recent Past, Current & Future Analysis for Enzyme Immunoassays by Product - Reagents & Kits, Analyzers / Instruments and Software & Services - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 153: Italy Historic Review for Enzyme Immunoassays by Product - Reagents & Kits, Analyzers / Instruments and Software & Services Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 154: Italy 15-Year Perspective for Enzyme Immunoassays by Product - Percentage Breakdown of Value Sales for Reagents & Kits, Analyzers / Instruments and Software & Services for the Years 2015, 2025 & 2030
  • TABLE 155: Italy Recent Past, Current & Future Analysis for Enzyme Immunoassays by Application - Cardiology, Endocrinology, Infectious Disease Testing, Autoimmune Diseases, Other Applications, Therapeutic Drug Monitoring and Oncology - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 156: Italy Historic Review for Enzyme Immunoassays by Application - Cardiology, Endocrinology, Infectious Disease Testing, Autoimmune Diseases, Other Applications, Therapeutic Drug Monitoring and Oncology Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 157: Italy 15-Year Perspective for Enzyme Immunoassays by Application - Percentage Breakdown of Value Sales for Cardiology, Endocrinology, Infectious Disease Testing, Autoimmune Diseases, Other Applications, Therapeutic Drug Monitoring and Oncology for the Years 2015, 2025 & 2030
  • TABLE 158: Italy Recent Past, Current & Future Analysis for Enzyme Immunoassays by End-Use - Hospitals, Blood Banks, Clinical Laboratories, Pharma & Biotech Companies, Academic Research Centers and Other End-Uses - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 159: Italy Historic Review for Enzyme Immunoassays by End-Use - Hospitals, Blood Banks, Clinical Laboratories, Pharma & Biotech Companies, Academic Research Centers and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 160: Italy 15-Year Perspective for Enzyme Immunoassays by End-Use - Percentage Breakdown of Value Sales for Hospitals, Blood Banks, Clinical Laboratories, Pharma & Biotech Companies, Academic Research Centers and Other End-Uses for the Years 2015, 2025 & 2030
  • TABLE 161: Italy Recent Past, Current & Future Analysis for Enzyme Immunoassays by Specimen - Blood, Saliva, Urine and Other Specimens - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 162: Italy Historic Review for Enzyme Immunoassays by Specimen - Blood, Saliva, Urine and Other Specimens Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 163: Italy 15-Year Perspective for Enzyme Immunoassays by Specimen - Percentage Breakdown of Value Sales for Blood, Saliva, Urine and Other Specimens for the Years 2015, 2025 & 2030
• UNITED KINGDOM
  • Enzyme Immunoassays Market Presence - Strong/Active/Niche/Trivial - Key Competitors in the United Kingdom for 2025 (E)
  • TABLE 164: UK Recent Past, Current & Future Analysis for Enzyme Immunoassays by Product - Reagents & Kits, Analyzers / Instruments and Software & Services - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 165: UK Historic Review for Enzyme Immunoassays by Product - Reagents & Kits, Analyzers / Instruments and Software & Services Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 166: UK 15-Year Perspective for Enzyme Immunoassays by Product - Percentage Breakdown of Value Sales for Reagents & Kits, Analyzers / Instruments and Software & Services for the Years 2015, 2025 & 2030
  • TABLE 167: UK Recent Past, Current & Future Analysis for Enzyme Immunoassays by Application - Cardiology, Endocrinology, Infectious Disease Testing, Autoimmune Diseases, Other Applications, Therapeutic Drug Monitoring and Oncology - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 168: UK Historic Review for Enzyme Immunoassays by Application - Cardiology, Endocrinology, Infectious Disease Testing, Autoimmune Diseases, Other Applications, Therapeutic Drug Monitoring and Oncology Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 169: UK 15-Year Perspective for Enzyme Immunoassays by Application - Percentage Breakdown of Value Sales for Cardiology, Endocrinology, Infectious Disease Testing, Autoimmune Diseases, Other Applications, Therapeutic Drug Monitoring and Oncology for the Years 2015, 2025 & 2030
  • TABLE 170: UK Recent Past, Current & Future Analysis for Enzyme Immunoassays by End-Use - Hospitals, Blood Banks, Clinical Laboratories, Pharma & Biotech Companies, Academic Research Centers and Other End-Uses - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 171: UK Historic Review for Enzyme Immunoassays by End-Use - Hospitals, Blood Banks, Clinical Laboratories, Pharma & Biotech Companies, Academic Research Centers and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 172: UK 15-Year Perspective for Enzyme Immunoassays by End-Use - Percentage Breakdown of Value Sales for Hospitals, Blood Banks, Clinical Laboratories, Pharma & Biotech Companies, Academic Research Centers and Other End-Uses for the Years 2015, 2025 & 2030
  • TABLE 173: UK Recent Past, Current & Future Analysis for Enzyme Immunoassays by Specimen - Blood, Saliva, Urine and Other Specimens - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 174: UK Historic Review for Enzyme Immunoassays by Specimen - Blood, Saliva, Urine and Other Specimens Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 175: UK 15-Year Perspective for Enzyme Immunoassays by Specimen - Percentage Breakdown of Value Sales for Blood, Saliva, Urine and Other Specimens for the Years 2015, 2025 & 2030
• SPAIN
  • TABLE 176: Spain Recent Past, Current & Future Analysis for Enzyme Immunoassays by Product - Reagents & Kits, Analyzers / Instruments and Software & Services - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 177: Spain Historic Review for Enzyme Immunoassays by Product - Reagents & Kits, Analyzers / Instruments and Software & Services Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 178: Spain 15-Year Perspective for Enzyme Immunoassays by Product - Percentage Breakdown of Value Sales for Reagents & Kits, Analyzers / Instruments and Software & Services for the Years 2015, 2025 & 2030
  • TABLE 179: Spain Recent Past, Current & Future Analysis for Enzyme Immunoassays by Application - Cardiology, Endocrinology, Infectious Disease Testing, Autoimmune Diseases, Other Applications, Therapeutic Drug Monitoring and Oncology - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 180: Spain Historic Review for Enzyme Immunoassays by Application - Cardiology, Endocrinology, Infectious Disease Testing, Autoimmune Diseases, Other Applications, Therapeutic Drug Monitoring and Oncology Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 181: Spain 15-Year Perspective for Enzyme Immunoassays by Application - Percentage Breakdown of Value Sales for Cardiology, Endocrinology, Infectious Disease Testing, Autoimmune Diseases, Other Applications, Therapeutic Drug Monitoring and Oncology for the Years 2015, 2025 & 2030
  • TABLE 182: Spain Recent Past, Current & Future Analysis for Enzyme Immunoassays by End-Use - Hospitals, Blood Banks, Clinical Laboratories, Pharma & Biotech Companies, Academic Research Centers and Other End-Uses - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 183: Spain Historic Review for Enzyme Immunoassays by End-Use - Hospitals, Blood Banks, Clinical Laboratories, Pharma & Biotech Companies, Academic Research Centers and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 184: Spain 15-Year Perspective for Enzyme Immunoassays by End-Use - Percentage Breakdown of Value Sales for Hospitals, Blood Banks, Clinical Laboratories, Pharma & Biotech Companies, Academic Research Centers and Other End-Uses for the Years 2015, 2025 & 2030
  • TABLE 185: Spain Recent Past, Current & Future Analysis for Enzyme Immunoassays by Specimen - Blood, Saliva, Urine and Other Specimens - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 186: Spain Historic Review for Enzyme Immunoassays by Specimen - Blood, Saliva, Urine and Other Specimens Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 187: Spain 15-Year Perspective for Enzyme Immunoassays by Specimen - Percentage Breakdown of Value Sales for Blood, Saliva, Urine and Other Specimens for the Years 2015, 2025 & 2030
• RUSSIA
  • TABLE 188: Russia Recent Past, Current & Future Analysis for Enzyme Immunoassays by Product - Reagents & Kits, Analyzers / Instruments and Software & Services - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 189: Russia Historic Review for Enzyme Immunoassays by Product - Reagents & Kits, Analyzers / Instruments and Software & Services Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 190: Russia 15-Year Perspective for Enzyme Immunoassays by Product - Percentage Breakdown of Value Sales for Reagents & Kits, Analyzers / Instruments and Software & Services for the Years 2015, 2025 & 2030
  • TABLE 191: Russia Recent Past, Current & Future Analysis for Enzyme Immunoassays by Application - Cardiology, Endocrinology, Infectious Disease Testing, Autoimmune Diseases, Other Applications, Therapeutic Drug Monitoring and Oncology - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 192: Russia Historic Review for Enzyme Immunoassays by Application - Cardiology, Endocrinology, Infectious Disease Testing, Autoimmune Diseases, Other Applications, Therapeutic Drug Monitoring and Oncology Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 193: Russia 15-Year Perspective for Enzyme Immunoassays by Application - Percentage Breakdown of Value Sales for Cardiology, Endocrinology, Infectious Disease Testing, Autoimmune Diseases, Other Applications, Therapeutic Drug Monitoring and Oncology for the Years 2015, 2025 & 2030
  • TABLE 194: Russia Recent Past, Current & Future Analysis for Enzyme Immunoassays by End-Use - Hospitals, Blood Banks, Clinical Laboratories, Pharma & Biotech Companies, Academic Research Centers and Other End-Uses - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 195: Russia Historic Review for Enzyme Immunoassays by End-Use - Hospitals, Blood Banks, Clinical Laboratories, Pharma & Biotech Companies, Academic Research Centers and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 196: Russia 15-Year Perspective for Enzyme Immunoassays by End-Use - Percentage Breakdown of Value Sales for Hospitals, Blood Banks, Clinical Laboratories, Pharma & Biotech Companies, Academic Research Centers and Other End-Uses for the Years 2015, 2025 & 2030
  • TABLE 197: Russia Recent Past, Current & Future Analysis for Enzyme Immunoassays by Specimen - Blood, Saliva, Urine and Other Specimens - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 198: Russia Historic Review for Enzyme Immunoassays by Specimen - Blood, Saliva, Urine and Other Specimens Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 199: Russia 15-Year Perspective for Enzyme Immunoassays by Specimen - Percentage Breakdown of Value Sales for Blood, Saliva, Urine and Other Specimens for the Years 2015, 2025 & 2030
• REST OF EUROPE
  • TABLE 200: Rest of Europe Recent Past, Current & Future Analysis for Enzyme Immunoassays by Product - Reagents & Kits, Analyzers / Instruments and Software & Services - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 201: Rest of Europe Historic Review for Enzyme Immunoassays by Product - Reagents & Kits, Analyzers / Instruments and Software & Services Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 202: Rest of Europe 15-Year Perspective for Enzyme Immunoassays by Product - Percentage Breakdown of Value Sales for Reagents & Kits, Analyzers / Instruments and Software & Services for the Years 2015, 2025 & 2030
  • TABLE 203: Rest of Europe Recent Past, Current & Future Analysis for Enzyme Immunoassays by Application - Cardiology, Endocrinology, Infectious Disease Testing, Autoimmune Diseases, Other Applications, Therapeutic Drug Monitoring and Oncology - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 204: Rest of Europe Historic Review for Enzyme Immunoassays by Application - Cardiology, Endocrinology, Infectious Disease Testing, Autoimmune Diseases, Other Applications, Therapeutic Drug Monitoring and Oncology Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 205: Rest of Europe 15-Year Perspective for Enzyme Immunoassays by Application - Percentage Breakdown of Value Sales for Cardiology, Endocrinology, Infectious Disease Testing, Autoimmune Diseases, Other Applications, Therapeutic Drug Monitoring and Oncology for the Years 2015, 2025 & 2030
  • TABLE 206: Rest of Europe Recent Past, Current & Future Analysis for Enzyme Immunoassays by End-Use - Hospitals, Blood Banks, Clinical Laboratories, Pharma & Biotech Companies, Academic Research Centers and Other End-Uses - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 207: Rest of Europe Historic Review for Enzyme Immunoassays by End-Use - Hospitals, Blood Banks, Clinical Laboratories, Pharma & Biotech Companies, Academic Research Centers and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 208: Rest of Europe 15-Year Perspective for Enzyme Immunoassays by End-Use - Percentage Breakdown of Value Sales for Hospitals, Blood Banks, Clinical Laboratories, Pharma & Biotech Companies, Academic Research Centers and Other End-Uses for the Years 2015, 2025 & 2030
  • TABLE 209: Rest of Europe Recent Past, Current & Future Analysis for Enzyme Immunoassays by Specimen - Blood, Saliva, Urine and Other Specimens - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 210: Rest of Europe Historic Review for Enzyme Immunoassays by Specimen - Blood, Saliva, Urine and Other Specimens Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 211: Rest of Europe 15-Year Perspective for Enzyme Immunoassays by Specimen - Percentage Breakdown of Value Sales for Blood, Saliva, Urine and Other Specimens for the Years 2015, 2025 & 2030
• ASIA-PACIFIC
  • Enzyme Immunoassays Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Asia-Pacific for 2025 (E)
  • TABLE 212: Asia-Pacific Recent Past, Current & Future Analysis for Enzyme Immunoassays by Geographic Region - Australia, India, South Korea and Rest of Asia-Pacific Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
  • TABLE 213: Asia-Pacific Historic Review for Enzyme Immunoassays by Geographic Region - Australia, India, South Korea and Rest of Asia-Pacific Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 214: Asia-Pacific 15-Year Perspective for Enzyme Immunoassays by Geographic Region - Percentage Breakdown of Value Sales for Australia, India, South Korea and Rest of Asia-Pacific Markets for Years 2015, 2025 & 2030
  • TABLE 215: Asia-Pacific Recent Past, Current & Future Analysis for Enzyme Immunoassays by Product - Reagents & Kits, Analyzers / Instruments and Software & Services - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 216: Asia-Pacific Historic Review for Enzyme Immunoassays by Product - Reagents & Kits, Analyzers / Instruments and Software & Services Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 217: Asia-Pacific 15-Year Perspective for Enzyme Immunoassays by Product - Percentage Breakdown of Value Sales for Reagents & Kits, Analyzers / Instruments and Software & Services for the Years 2015, 2025 & 2030
  • TABLE 218: Asia-Pacific Recent Past, Current & Future Analysis for Enzyme Immunoassays by Application - Cardiology, Endocrinology, Infectious Disease Testing, Autoimmune Diseases, Other Applications, Therapeutic Drug Monitoring and Oncology - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 219: Asia-Pacific Historic Review for Enzyme Immunoassays by Application - Cardiology, Endocrinology, Infectious Disease Testing, Autoimmune Diseases, Other Applications, Therapeutic Drug Monitoring and Oncology Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 220: Asia-Pacific 15-Year Perspective for Enzyme Immunoassays by Application - Percentage Breakdown of Value Sales for Cardiology, Endocrinology, Infectious Disease Testing, Autoimmune Diseases, Other Applications, Therapeutic Drug Monitoring and Oncology for the Years 2015, 2025 & 2030
  • TABLE 221: Asia-Pacific Recent Past, Current & Future Analysis for Enzyme Immunoassays by End-Use - Hospitals, Blood Banks, Clinical Laboratories, Pharma & Biotech Companies, Academic Research Centers and Other End-Uses - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 222: Asia-Pacific Historic Review for Enzyme Immunoassays by End-Use - Hospitals, Blood Banks, Clinical Laboratories, Pharma & Biotech Companies, Academic Research Centers and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 223: Asia-Pacific 15-Year Perspective for Enzyme Immunoassays by End-Use - Percentage Breakdown of Value Sales for Hospitals, Blood Banks, Clinical Laboratories, Pharma & Biotech Companies, Academic Research Centers and Other End-Uses for the Years 2015, 2025 & 2030
  • TABLE 224: Asia-Pacific Recent Past, Current & Future Analysis for Enzyme Immunoassays by Specimen - Blood, Saliva, Urine and Other Specimens - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 225: Asia-Pacific Historic Review for Enzyme Immunoassays by Specimen - Blood, Saliva, Urine and Other Specimens Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 226: Asia-Pacific 15-Year Perspective for Enzyme Immunoassays by Specimen - Percentage Breakdown of Value Sales for Blood, Saliva, Urine and Other Specimens for the Years 2015, 2025 & 2030
• AUSTRALIA
  • Enzyme Immunoassays Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Australia for 2025 (E)
  • TABLE 227: Australia Recent Past, Current & Future Analysis for Enzyme Immunoassays by Product - Reagents & Kits, Analyzers / Instruments and Software & Services - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 228: Australia Historic Review for Enzyme Immunoassays by Product - Reagents & Kits, Analyzers / Instruments and Software & Services Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 229: Australia 15-Year Perspective for Enzyme Immunoassays by Product - Percentage Breakdown of Value Sales for Reagents & Kits, Analyzers / Instruments and Software & Services for the Years 2015, 2025 & 2030
  • TABLE 230: Australia Recent Past, Current & Future Analysis for Enzyme Immunoassays by Application - Cardiology, Endocrinology, Infectious Disease Testing, Autoimmune Diseases, Other Applications, Therapeutic Drug Monitoring and Oncology - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 231: Australia Historic Review for Enzyme Immunoassays by Application - Cardiology, Endocrinology, Infectious Disease Testing, Autoimmune Diseases, Other Applications, Therapeutic Drug Monitoring and Oncology Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 232: Australia 15-Year Perspective for Enzyme Immunoassays by Application - Percentage Breakdown of Value Sales for Cardiology, Endocrinology, Infectious Disease Testing, Autoimmune Diseases, Other Applications, Therapeutic Drug Monitoring and Oncology for the Years 2015, 2025 & 2030
  • TABLE 233: Australia Recent Past, Current & Future Analysis for Enzyme Immunoassays by End-Use - Hospitals, Blood Banks, Clinical Laboratories, Pharma & Biotech Companies, Academic Research Centers and Other End-Uses - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 234: Australia Historic Review for Enzyme Immunoassays by End-Use - Hospitals, Blood Banks, Clinical Laboratories, Pharma & Biotech Companies, Academic Research Centers and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 235: Australia 15-Year Perspective for Enzyme Immunoassays by End-Use - Percentage Breakdown of Value Sales for Hospitals, Blood Banks, Clinical Laboratories, Pharma & Biotech Companies, Academic Research Centers and Other End-Uses for the Years 2015, 2025 & 2030
  • TABLE 236: Australia Recent Past, Current & Future Analysis for Enzyme Immunoassays by Specimen - Blood, Saliva, Urine and Other Specimens - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 237: Australia Historic Review for Enzyme Immunoassays by Specimen - Blood, Saliva, Urine and Other Specimens Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 238: Australia 15-Year Perspective for Enzyme Immunoassays by Specimen - Percentage Breakdown of Value Sales for Blood, Saliva, Urine and Other Specimens for the Years 2015, 2025 & 2030
• INDIA
  • Enzyme Immunoassays Market Presence - Strong/Active/Niche/Trivial - Key Competitors in India for 2025 (E)
  • TABLE 239: India Recent Past, Current & Future Analysis for Enzyme Immunoassays by Product - Reagents & Kits, Analyzers / Instruments and Software & Services - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 240: India Historic Review for Enzyme Immunoassays by Product - Reagents & Kits, Analyzers / Instruments and Software & Services Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 241: India 15-Year Perspective for Enzyme Immunoassays by Product - Percentage Breakdown of Value Sales for Reagents & Kits, Analyzers / Instruments and Software & Services for the Years 2015, 2025 & 2030
  • TABLE 242: India Recent Past, Current & Future Analysis for Enzyme Immunoassays by Application - Cardiology, Endocrinology, Infectious Disease Testing, Autoimmune Diseases, Other Applications, Therapeutic Drug Monitoring and Oncology - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 243: India Historic Review for Enzyme Immunoassays by Application - Cardiology, Endocrinology, Infectious Disease Testing, Autoimmune Diseases, Other Applications, Therapeutic Drug Monitoring and Oncology Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 244: India 15-Year Perspective for Enzyme Immunoassays by Application - Percentage Breakdown of Value Sales for Cardiology, Endocrinology, Infectious Disease Testing, Autoimmune Diseases, Other Applications, Therapeutic Drug Monitoring and Oncology for the Years 2015, 2025 & 2030
  • TABLE 245: India Recent Past, Current & Future Analysis for Enzyme Immunoassays by End-Use - Hospitals, Blood Banks, Clinical Laboratories, Pharma & Biotech Companies, Academic Research Centers and Other End-Uses - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 246: India Historic Review for Enzyme Immunoassays by End-Use - Hospitals, Blood Banks, Clinical Laboratories, Pharma & Biotech Companies, Academic Research Centers and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 247: India 15-Year Perspective for Enzyme Immunoassays by End-Use - Percentage Breakdown of Value Sales for Hospitals, Blood Banks, Clinical Laboratories, Pharma & Biotech Companies, Academic Research Centers and Other End-Uses for the Years 2015, 2025 & 2030
  • TABLE 248: India Recent Past, Current & Future Analysis for Enzyme Immunoassays by Specimen - Blood, Saliva, Urine and Other Specimens - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 249: India Historic Review for Enzyme Immunoassays by Specimen - Blood, Saliva, Urine and Other Specimens Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 250: India 15-Year Perspective for Enzyme Immunoassays by Specimen - Percentage Breakdown of Value Sales for Blood, Saliva, Urine and Other Specimens for the Years 2015, 2025 & 2030
• SOUTH KOREA
  • TABLE 251: South Korea Recent Past, Current & Future Analysis for Enzyme Immunoassays by Product - Reagents & Kits, Analyzers / Instruments and Software & Services - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 252: South Korea Historic Review for Enzyme Immunoassays by Product - Reagents & Kits, Analyzers / Instruments and Software & Services Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 253: South Korea 15-Year Perspective for Enzyme Immunoassays by Product - Percentage Breakdown of Value Sales for Reagents & Kits, Analyzers / Instruments and Software & Services for the Years 2015, 2025 & 2030
  • TABLE 254: South Korea Recent Past, Current & Future Analysis for Enzyme Immunoassays by Application - Cardiology, Endocrinology, Infectious Disease Testing, Autoimmune Diseases, Other Applications, Therapeutic Drug Monitoring and Oncology - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 255: South Korea Historic Review for Enzyme Immunoassays by Application - Cardiology, Endocrinology, Infectious Disease Testing, Autoimmune Diseases, Other Applications, Therapeutic Drug Monitoring and Oncology Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 256: South Korea 15-Year Perspective for Enzyme Immunoassays by Application - Percentage Breakdown of Value Sales for Cardiology, Endocrinology, Infectious Disease Testing, Autoimmune Diseases, Other Applications, Therapeutic Drug Monitoring and Oncology for the Years 2015, 2025 & 2030
  • TABLE 257: South Korea Recent Past, Current & Future Analysis for Enzyme Immunoassays by End-Use - Hospitals, Blood Banks, Clinical Laboratories, Pharma & Biotech Companies, Academic Research Centers and Other End-Uses - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 258: South Korea Historic Review for Enzyme Immunoassays by End-Use - Hospitals, Blood Banks, Clinical Laboratories, Pharma & Biotech Companies, Academic Research Centers and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 259: South Korea 15-Year Perspective for Enzyme Immunoassays by End-Use - Percentage Breakdown of Value Sales for Hospitals, Blood Banks, Clinical Laboratories, Pharma & Biotech Companies, Academic Research Centers and Other End-Uses for the Years 2015, 2025 & 2030
  • TABLE 260: South Korea Recent Past, Current & Future Analysis for Enzyme Immunoassays by Specimen - Blood, Saliva, Urine and Other Specimens - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 261: South Korea Historic Review for Enzyme Immunoassays by Specimen - Blood, Saliva, Urine and Other Specimens Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 262: South Korea 15-Year Perspective for Enzyme Immunoassays by Specimen - Percentage Breakdown of Value Sales for Blood, Saliva, Urine and Other Specimens for the Years 2015, 2025 & 2030
• REST OF ASIA-PACIFIC
  • TABLE 263: Rest of Asia-Pacific Recent Past, Current & Future Analysis for Enzyme Immunoassays by Product - Reagents & Kits, Analyzers / Instruments and Software & Services - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 264: Rest of Asia-Pacific Historic Review for Enzyme Immunoassays by Product - Reagents & Kits, Analyzers / Instruments and Software & Services Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 265: Rest of Asia-Pacific 15-Year Perspective for Enzyme Immunoassays by Product - Percentage Breakdown of Value Sales for Reagents & Kits, Analyzers / Instruments and Software & Services for the Years 2015, 2025 & 2030
  • TABLE 266: Rest of Asia-Pacific Recent Past, Current & Future Analysis for Enzyme Immunoassays by Application - Cardiology, Endocrinology, Infectious Disease Testing, Autoimmune Diseases, Other Applications, Therapeutic Drug Monitoring and Oncology - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 267: Rest of Asia-Pacific Historic Review for Enzyme Immunoassays by Application - Cardiology, Endocrinology, Infectious Disease Testing, Autoimmune Diseases, Other Applications, Therapeutic Drug Monitoring and Oncology Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 268: Rest of Asia-Pacific 15-Year Perspective for Enzyme Immunoassays by Application - Percentage Breakdown of Value Sales for Cardiology, Endocrinology, Infectious Disease Testing, Autoimmune Diseases, Other Applications, Therapeutic Drug Monitoring and Oncology for the Years 2015, 2025 & 2030
  • TABLE 269: Rest of Asia-Pacific Recent Past, Current & Future Analysis for Enzyme Immunoassays by End-Use - Hospitals, Blood Banks, Clinical Laboratories, Pharma & Biotech Companies, Academic Research Centers and Other End-Uses - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 270: Rest of Asia-Pacific Historic Review for Enzyme Immunoassays by End-Use - Hospitals, Blood Banks, Clinical Laboratories, Pharma & Biotech Companies, Academic Research Centers and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 271: Rest of Asia-Pacific 15-Year Perspective for Enzyme Immunoassays by End-Use - Percentage Breakdown of Value Sales for Hospitals, Blood Banks, Clinical Laboratories, Pharma & Biotech Companies, Academic Research Centers and Other End-Uses for the Years 2015, 2025 & 2030
  • TABLE 272: Rest of Asia-Pacific Recent Past, Current & Future Analysis for Enzyme Immunoassays by Specimen - Blood, Saliva, Urine and Other Specimens - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 273: Rest of Asia-Pacific Historic Review for Enzyme Immunoassays by Specimen - Blood, Saliva, Urine and Other Specimens Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 274: Rest of Asia-Pacific 15-Year Perspective for Enzyme Immunoassays by Specimen - Percentage Breakdown of Value Sales for Blood, Saliva, Urine and Other Specimens for the Years 2015, 2025 & 2030
• LATIN AMERICA
  • Enzyme Immunoassays Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Latin America for 2025 (E)
  • TABLE 275: Latin America Recent Past, Current & Future Analysis for Enzyme Immunoassays by Geographic Region - Argentina, Brazil, Mexico and Rest of Latin America Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
  • TABLE 276: Latin America Historic Review for Enzyme Immunoassays by Geographic Region - Argentina, Brazil, Mexico and Rest of Latin America Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 277: Latin America 15-Year Perspective for Enzyme Immunoassays by Geographic Region - Percentage Breakdown of Value Sales for Argentina, Brazil, Mexico and Rest of Latin America Markets for Years 2015, 2025 & 2030
  • TABLE 278: Latin America Recent Past, Current & Future Analysis for Enzyme Immunoassays by Product - Reagents & Kits, Analyzers / Instruments and Software & Services - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 279: Latin America Historic Review for Enzyme Immunoassays by Product - Reagents & Kits, Analyzers / Instruments and Software & Services Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 280: Latin America 15-Year Perspective for Enzyme Immunoassays by Product - Percentage Breakdown of Value Sales for Reagents & Kits, Analyzers / Instruments and Software & Services for the Years 2015, 2025 & 2030
  • TABLE 281: Latin America Recent Past, Current & Future Analysis for Enzyme Immunoassays by Application - Cardiology, Endocrinology, Infectious Disease Testing, Autoimmune Diseases, Other Applications, Therapeutic Drug Monitoring and Oncology - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 282: Latin America Historic Review for Enzyme Immunoassays by Application - Cardiology, Endocrinology, Infectious Disease Testing, Autoimmune Diseases, Other Applications, Therapeutic Drug Monitoring and Oncology Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 283: Latin America 15-Year Perspective for Enzyme Immunoassays by Application - Percentage Breakdown of Value Sales for Cardiology, Endocrinology, Infectious Disease Testing, Autoimmune Diseases, Other Applications, Therapeutic Drug Monitoring and Oncology for the Years 2015, 2025 & 2030
  • TABLE 284: Latin America Recent Past, Current & Future Analysis for Enzyme Immunoassays by End-Use - Hospitals, Blood Banks, Clinical Laboratories, Pharma & Biotech Companies, Academic Research Centers and Other End-Uses - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 285: Latin America Historic Review for Enzyme Immunoassays by End-Use - Hospitals, Blood Banks, Clinical Laboratories, Pharma & Biotech Companies, Academic Research Centers and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 286: Latin America 15-Year Perspective for Enzyme Immunoassays by End-Use - Percentage Breakdown of Value Sales for Hospitals, Blood Banks, Clinical Laboratories, Pharma & Biotech Companies, Academic Research Centers and Other End-Uses for the Years 2015, 2025 & 2030
  • TABLE 287: Latin America Recent Past, Current & Future Analysis for Enzyme Immunoassays by Specimen - Blood, Saliva, Urine and Other Specimens - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 288: Latin America Historic Review for Enzyme Immunoassays by Specimen - Blood, Saliva, Urine and Other Specimens Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 289: Latin America 15-Year Perspective for Enzyme Immunoassays by Specimen - Percentage Breakdown of Value Sales for Blood, Saliva, Urine and Other Specimens for the Years 2015, 2025 & 2030
• ARGENTINA
  • TABLE 290: Argentina Recent Past, Current & Future Analysis for Enzyme Immunoassays by Product - Reagents & Kits, Analyzers / Instruments and Software & Services - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 291: Argentina Historic Review for Enzyme Immunoassays by Product - Reagents & Kits, Analyzers / Instruments and Software & Services Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 292: Argentina 15-Year Perspective for Enzyme Immunoassays by Product - Percentage Breakdown of Value Sales for Reagents & Kits, Analyzers / Instruments and Software & Services for the Years 2015, 2025 & 2030
  • TABLE 293: Argentina Recent Past, Current & Future Analysis for Enzyme Immunoassays by Application - Cardiology, Endocrinology, Infectious Disease Testing, Autoimmune Diseases, Other Applications, Therapeutic Drug Monitoring and Oncology - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 294: Argentina Historic Review for Enzyme Immunoassays by Application - Cardiology, Endocrinology, Infectious Disease Testing, Autoimmune Diseases, Other Applications, Therapeutic Drug Monitoring and Oncology Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 295: Argentina 15-Year Perspective for Enzyme Immunoassays by Application - Percentage Breakdown of Value Sales for Cardiology, Endocrinology, Infectious Disease Testing, Autoimmune Diseases, Other Applications, Therapeutic Drug Monitoring and Oncology for the Years 2015, 2025 & 2030
  • TABLE 296: Argentina Recent Past, Current & Future Analysis for Enzyme Immunoassays by End-Use - Hospitals, Blood Banks, Clinical Laboratories, Pharma & Biotech Companies, Academic Research Centers and Other End-Uses - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 297: Argentina Historic Review for Enzyme Immunoassays by End-Use - Hospitals, Blood Banks, Clinical Laboratories, Pharma & Biotech Companies, Academic Research Centers and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 298: Argentina 15-Year Perspective for Enzyme Immunoassays by End-Use - Percentage Breakdown of Value Sales for Hospitals, Blood Banks, Clinical Laboratories, Pharma & Biotech Companies, Academic Research Centers and Other End-Uses for the Years 2015, 2025 & 2030
  • TABLE 299: Argentina Recent Past, Current & Future Analysis for Enzyme Immunoassays by Specimen - Blood, Saliva, Urine and Other Specimens - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 300: Argentina Historic Review for Enzyme Immunoassays by Specimen - Blood, Saliva, Urine and Other Specimens Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 301: Argentina 15-Year Perspective for Enzyme Immunoassays by Specimen - Percentage Breakdown of Value Sales for Blood, Saliva, Urine and Other Specimens for the Years 2015, 2025 & 2030
• BRAZIL
  • TABLE 302: Brazil Recent Past, Current & Future Analysis for Enzyme Immunoassays by Product - Reagents & Kits, Analyzers / Instruments and Software & Services - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 303: Brazil Historic Review for Enzyme Immunoassays by Product - Reagents & Kits, Analyzers / Instruments and Software & Services Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 304: Brazil 15-Year Perspective for Enzyme Immunoassays by Product - Percentage Breakdown of Value Sales for Reagents & Kits, Analyzers / Instruments and Software & Services for the Years 2015, 2025 & 2030
  • TABLE 305: Brazil Recent Past, Current & Future Analysis for Enzyme Immunoassays by Application - Cardiology, Endocrinology, Infectious Disease Testing, Autoimmune Diseases, Other Applications, Therapeutic Drug Monitoring and Oncology - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 306: Brazil Historic Review for Enzyme Immunoassays by Application - Cardiology, Endocrinology, Infectious Disease Testing, Autoimmune Diseases, Other Applications, Therapeutic Drug Monitoring and Oncology Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 307: Brazil 15-Year Perspective for Enzyme Immunoassays by Application - Percentage Breakdown of Value Sales for Cardiology, Endocrinology, Infectious Disease Testing, Autoimmune Diseases, Other Applications, Therapeutic Drug Monitoring and Oncology for the Years 2015, 2025 & 2030
  • TABLE 308: Brazil Recent Past, Current & Future Analysis for Enzyme Immunoassays by End-Use - Hospitals, Blood Banks, Clinical Laboratories, Pharma & Biotech Companies, Academic Research Centers and Other End-Uses - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 309: Brazil Historic Review for Enzyme Immunoassays by End-Use - Hospitals, Blood Banks, Clinical Laboratories, Pharma & Biotech Companies, Academic Research Centers and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 310: Brazil 15-Year Perspective for Enzyme Immunoassays by End-Use - Percentage Breakdown of Value Sales for Hospitals, Blood Banks, Clinical Laboratories, Pharma & Biotech Companies, Academic Research Centers and Other End-Uses for the Years 2015, 2025 & 2030
  • TABLE 311: Brazil Recent Past, Current & Future Analysis for Enzyme Immunoassays by Specimen - Blood, Saliva, Urine and Other Specimens - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 312: Brazil Historic Review for Enzyme Immunoassays by Specimen - Blood, Saliva, Urine and Other Specimens Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 313: Brazil 15-Year Perspective for Enzyme Immunoassays by Specimen - Percentage Breakdown of Value Sales for Blood, Saliva, Urine and Other Specimens for the Years 2015, 2025 & 2030
• MEXICO
  • TABLE 314: Mexico Recent Past, Current & Future Analysis for Enzyme Immunoassays by Product - Reagents & Kits, Analyzers / Instruments and Software & Services - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 315: Mexico Historic Review for Enzyme Immunoassays by Product - Reagents & Kits, Analyzers / Instruments and Software & Services Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 316: Mexico 15-Year Perspective for Enzyme Immunoassays by Product - Percentage Breakdown of Value Sales for Reagents & Kits, Analyzers / Instruments and Software & Services for the Years 2015, 2025 & 2030
  • TABLE 317: Mexico Recent Past, Current & Future Analysis for Enzyme Immunoassays by Application - Cardiology, Endocrinology, Infectious Disease Testing, Autoimmune Diseases, Other Applications, Therapeutic Drug Monitoring and Oncology - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 318: Mexico Historic Review for Enzyme Immunoassays by Application - Cardiology, Endocrinology, Infectious Disease Testing, Autoimmune Diseases, Other Applications, Therapeutic Drug Monitoring and Oncology Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 319: Mexico 15-Year Perspective for Enzyme Immunoassays by Application - Percentage Breakdown of Value Sales for Cardiology, Endocrinology, Infectious Disease Testing, Autoimmune Diseases, Other Applications, Therapeutic Drug Monitoring and Oncology for the Years 2015, 2025 & 2030
  • TABLE 320: Mexico Recent Past, Current & Future Analysis for Enzyme Immunoassays by End-Use - Hospitals, Blood Banks, Clinical Laboratories, Pharma & Biotech Companies, Academic Research Centers and Other End-Uses - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 321: Mexico Historic Review for Enzyme Immunoassays by End-Use - Hospitals, Blood Banks, Clinical Laboratories, Pharma & Biotech Companies, Academic Research Centers and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 322: Mexico 15-Year Perspective for Enzyme Immunoassays by End-Use - Percentage Breakdown of Value Sales for Hospitals, Blood Banks, Clinical Laboratories, Pharma & Biotech Companies, Academic Research Centers and Other End-Uses for the Years 2015, 2025 & 2030
  • TABLE 323: Mexico Recent Past, Current & Future Analysis for Enzyme Immunoassays by Specimen - Blood, Saliva, Urine and Other Specimens - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 324: Mexico Historic Review for Enzyme Immunoassays by Specimen - Blood, Saliva, Urine and Other Specimens Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 325: Mexico 15-Year Perspective for Enzyme Immunoassays by Specimen - Percentage Breakdown of Value Sales for Blood, Saliva, Urine and Other Specimens for the Years 2015, 2025 & 2030
• REST OF LATIN AMERICA
  • TABLE 326: Rest of Latin America Recent Past, Current & Future Analysis for Enzyme Immunoassays by Product - Reagents & Kits, Analyzers / Instruments and Software & Services - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 327: Rest of Latin America Historic Review for Enzyme Immunoassays by Product - Reagents & Kits, Analyzers / Instruments and Software & Services Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 328: Rest of Latin America 15-Year Perspective for Enzyme Immunoassays by Product - Percentage Breakdown of Value Sales for Reagents & Kits, Analyzers / Instruments and Software & Services for the Years 2015, 2025 & 2030
  • TABLE 329: Rest of Latin America Recent Past, Current & Future Analysis for Enzyme Immunoassays by Application - Cardiology, Endocrinology, Infectious Disease Testing, Autoimmune Diseases, Other Applications, Therapeutic Drug Monitoring and Oncology - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 330: Rest of Latin America Historic Review for Enzyme Immunoassays by Application - Cardiology, Endocrinology, Infectious Disease Testing, Autoimmune Diseases, Other Applications, Therapeutic Drug Monitoring and Oncology Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 331: Rest of Latin America 15-Year Perspective for Enzyme Immunoassays by Application - Percentage Breakdown of Value Sales for Cardiology, Endocrinology, Infectious Disease Testing, Autoimmune Diseases, Other Applications, Therapeutic Drug Monitoring and Oncology for the Years 2015, 2025 & 2030
  • TABLE 332: Rest of Latin America Recent Past, Current & Future Analysis for Enzyme Immunoassays by End-Use - Hospitals, Blood Banks, Clinical Laboratories, Pharma & Biotech Companies, Academic Research Centers and Other End-Uses - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 333: Rest of Latin America Historic Review for Enzyme Immunoassays by End-Use - Hospitals, Blood Banks, Clinical Laboratories, Pharma & Biotech Companies, Academic Research Centers and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 334: Rest of Latin America 15-Year Perspective for Enzyme Immunoassays by End-Use - Percentage Breakdown of Value Sales for Hospitals, Blood Banks, Clinical Laboratories, Pharma & Biotech Companies, Academic Research Centers and Other End-Uses for the Years 2015, 2025 & 2030
  • TABLE 335: Rest of Latin America Recent Past, Current & Future Analysis for Enzyme Immunoassays by Specimen - Blood, Saliva, Urine and Other Specimens - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 336: Rest of Latin America Historic Review for Enzyme Immunoassays by Specimen - Blood, Saliva, Urine and Other Specimens Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 337: Rest of Latin America 15-Year Perspective for Enzyme Immunoassays by Specimen - Percentage Breakdown of Value Sales for Blood, Saliva, Urine and Other Specimens for the Years 2015, 2025 & 2030
• MIDDLE EAST
  • Enzyme Immunoassays Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Middle East for 2025 (E)
  • TABLE 338: Middle East Recent Past, Current & Future Analysis for Enzyme Immunoassays by Geographic Region - Iran, Israel, Saudi Arabia, UAE and Rest of Middle East Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
  • TABLE 339: Middle East Historic Review for Enzyme Immunoassays by Geographic Region - Iran, Israel, Saudi Arabia, UAE and Rest of Middle East Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 340: Middle East 15-Year Perspective for Enzyme Immunoassays by Geographic Region - Percentage Breakdown of Value Sales for Iran, Israel, Saudi Arabia, UAE and Rest of Middle East Markets for Years 2015, 2025 & 2030
  • TABLE 341: Middle East Recent Past, Current & Future Analysis for Enzyme Immunoassays by Product - Reagents & Kits, Analyzers / Instruments and Software & Services - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 342: Middle East Historic Review for Enzyme Immunoassays by Product - Reagents & Kits, Analyzers / Instruments and Software & Services Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 343: Middle East 15-Year Perspective for Enzyme Immunoassays by Product - Percentage Breakdown of Value Sales for Reagents & Kits, Analyzers / Instruments and Software & Services for the Years 2015, 2025 & 2030
  • TABLE 344: Middle East Recent Past, Current & Future Analysis for Enzyme Immunoassays by Application - Cardiology, Endocrinology, Infectious Disease Testing, Autoimmune Diseases, Other Applications, Therapeutic Drug Monitoring and Oncology - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 345: Middle East Historic Review for Enzyme Immunoassays by Application - Cardiology, Endocrinology, Infectious Disease Testing, Autoimmune Diseases, Other Applications, Therapeutic Drug Monitoring and Oncology Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 346: Middle East 15-Year Perspective for Enzyme Immunoassays by Application - Percentage Breakdown of Value Sales for Cardiology, Endocrinology, Infectious Disease Testing, Autoimmune Diseases, Other Applications, Therapeutic Drug Monitoring and Oncology for the Years 2015, 2025 & 2030
  • TABLE 347: Middle East Recent Past, Current & Future Analysis for Enzyme Immunoassays by End-Use - Hospitals, Blood Banks, Clinical Laboratories, Pharma & Biotech Companies, Academic Research Centers and Other End-Uses - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 348: Middle East Historic Review for Enzyme Immunoassays by End-Use - Hospitals, Blood Banks, Clinical Laboratories, Pharma & Biotech Companies, Academic Research Centers and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 349: Middle East 15-Year Perspective for Enzyme Immunoassays by End-Use - Percentage Breakdown of Value Sales for Hospitals, Blood Banks, Clinical Laboratories, Pharma & Biotech Companies, Academic Research Centers and Other End-Uses for the Years 2015, 2025 & 2030
  • TABLE 350: Middle East Recent Past, Current & Future Analysis for Enzyme Immunoassays by Specimen - Blood, Saliva, Urine and Other Specimens - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 351: Middle East Historic Review for Enzyme Immunoassays by Specimen - Blood, Saliva, Urine and Other Specimens Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 352: Middle East 15-Year Perspective for Enzyme Immunoassays by Specimen - Percentage Breakdown of Value Sales for Blood, Saliva, Urine and Other Specimens for the Years 2015, 2025 & 2030
• IRAN
  • TABLE 353: Iran Recent Past, Current & Future Analysis for Enzyme Immunoassays by Product - Reagents & Kits, Analyzers / Instruments and Software & Services - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 354: Iran Historic Review for Enzyme Immunoassays by Product - Reagents & Kits, Analyzers / Instruments and Software & Services Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 355: Iran 15-Year Perspective for Enzyme Immunoassays by Product - Percentage Breakdown of Value Sales for Reagents & Kits, Analyzers / Instruments and Software & Services for the Years 2015, 2025 & 2030
  • TABLE 356: Iran Recent Past, Current & Future Analysis for Enzyme Immunoassays by Application - Cardiology, Endocrinology, Infectious Disease Testing, Autoimmune Diseases, Other Applications, Therapeutic Drug Monitoring and Oncology - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 357: Iran Historic Review for Enzyme Immunoassays by Application - Cardiology, Endocrinology, Infectious Disease Testing, Autoimmune Diseases, Other Applications, Therapeutic Drug Monitoring and Oncology Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 358: Iran 15-Year Perspective for Enzyme Immunoassays by Application - Percentage Breakdown of Value Sales for Cardiology, Endocrinology, Infectious Disease Testing, Autoimmune Diseases, Other Applications, Therapeutic Drug Monitoring and Oncology for the Years 2015, 2025 & 2030
  • TABLE 359: Iran Recent Past, Current & Future Analysis for Enzyme Immunoassays by End-Use - Hospitals, Blood Banks, Clinical Laboratories, Pharma & Biotech Companies, Academic Research Centers and Other End-Uses - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 360: Iran Historic Review for Enzyme Immunoassays by End-Use - Hospitals, Blood Banks, Clinical Laboratories, Pharma & Biotech Companies, Academic Research Centers and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 361: Iran 15-Year Perspective for Enzyme Immunoassays by End-Use - Percentage Breakdown of Value Sales for Hospitals, Blood Banks, Clinical Laboratories, Pharma & Biotech Companies, Academic Research Centers and Other End-Uses for the Years 2015, 2025 & 2030
  • TABLE 362: Iran Recent Past, Current & Future Analysis for Enzyme Immunoassays by Specimen - Blood, Saliva, Urine and Other Specimens - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 363: Iran Historic Review for Enzyme Immunoassays by Specimen - Blood, Saliva, Urine and Other Specimens Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 364: Iran 15-Year Perspective for Enzyme Immunoassays by Specimen - Percentage Breakdown of Value Sales for Blood, Saliva, Urine and Other Specimens for the Years 2015, 2025 & 2030
• ISRAEL
  • TABLE 365: Israel Recent Past, Current & Future Analysis for Enzyme Immunoassays by Product - Reagents & Kits, Analyzers / Instruments and Software & Services - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 366: Israel Historic Review for Enzyme Immunoassays by Product - Reagents & Kits, Analyzers / Instruments and Software & Services Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 367: Israel 15-Year Perspective for Enzyme Immunoassays by Product - Percentage Breakdown of Value Sales for Reagents & Kits, Analyzers / Instruments and Software & Services for the Years 2015, 2025 & 2030
  • TABLE 368: Israel Recent Past, Current & Future Analysis for Enzyme Immunoassays by Application - Cardiology, Endocrinology, Infectious Disease Testing, Autoimmune Diseases, Other Applications, Therapeutic Drug Monitoring and Oncology - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 369: Israel Historic Review for Enzyme Immunoassays by Application - Cardiology, Endocrinology, Infectious Disease Testing, Autoimmune Diseases, Other Applications, Therapeutic Drug Monitoring and Oncology Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 370: Israel 15-Year Perspective for Enzyme Immunoassays by Application - Percentage Breakdown of Value Sales for Cardiology, Endocrinology, Infectious Disease Testing, Autoimmune Diseases, Other Applications, Therapeutic Drug Monitoring and Oncology for the Years 2015, 2025 & 2030
  • TABLE 371: Israel Recent Past, Current & Future Analysis for Enzyme Immunoassays by End-Use - Hospitals, Blood Banks, Clinical Laboratories, Pharma & Biotech Companies, Academic Research Centers and Other End-Uses - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 372: Israel Historic Review for Enzyme Immunoassays by End-Use - Hospitals, Blood Banks, Clinical Laboratories, Pharma & Biotech Companies, Academic Research Centers and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 373: Israel 15-Year Perspective for Enzyme Immunoassays by End-Use - Percentage Breakdown of Value Sales for Hospitals, Blood Banks, Clinical Laboratories, Pharma & Biotech Companies, Academic Research Centers and Other End-Uses for the Years 2015, 2025 & 2030
  • TABLE 374: Israel Recent Past, Current & Future Analysis for Enzyme Immunoassays by Specimen - Blood, Saliva, Urine and Other Specimens - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 375: Israel Historic Review for Enzyme Immunoassays by Specimen - Blood, Saliva, Urine and Other Specimens Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 376: Israel 15-Year Perspective for Enzyme Immunoassays by Specimen - Percentage Breakdown of Value Sales for Blood, Saliva, Urine and Other Specimens for the Years 2015, 2025 & 2030
• SAUDI ARABIA
  • TABLE 377: Saudi Arabia Recent Past, Current & Future Analysis for Enzyme Immunoassays by Product - Reagents & Kits, Analyzers / Instruments and Software & Services - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 378: Saudi Arabia Historic Review for Enzyme Immunoassays by Product - Reagents & Kits, Analyzers / Instruments and Software & Services Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 379: Saudi Arabia 15-Year Perspective for Enzyme Immunoassays by Product - Percentage Breakdown of Value Sales for Reagents & Kits, Analyzers / Instruments and Software & Services for the Years 2015, 2025 & 2030
  • TABLE 380: Saudi Arabia Recent Past, Current & Future Analysis for Enzyme Immunoassays by Application - Cardiology, Endocrinology, Infectious Disease Testing, Autoimmune Diseases, Other Applications, Therapeutic Drug Monitoring and Oncology - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 381: Saudi Arabia Historic Review for Enzyme Immunoassays by Application - Cardiology, Endocrinology, Infectious Disease Testing, Autoimmune Diseases, Other Applications, Therapeutic Drug Monitoring and Oncology Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 382: Saudi Arabia 15-Year Perspective for Enzyme Immunoassays by Application - Percentage Breakdown of Value Sales for Cardiology, Endocrinology, Infectious Disease Testing, Autoimmune Diseases, Other Applications, Therapeutic Drug Monitoring and Oncology for the Years 2015, 2025 & 2030
  • TABLE 383: Saudi Arabia Recent Past, Current & Future Analysis for Enzyme Immunoassays by End-Use - Hospitals, Blood Banks, Clinical Laboratories, Pharma & Biotech Companies, Academic Research Centers and Other End-Uses - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 384: Saudi Arabia Historic Review for Enzyme Immunoassays by End-Use - Hospitals, Blood Banks, Clinical Laboratories, Pharma & Biotech Companies, Academic Research Centers and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 385: Saudi Arabia 15-Year Perspective for Enzyme Immunoassays by End-Use - Percentage Breakdown of Value Sales for Hospitals, Blood Banks, Clinical Laboratories, Pharma & Biotech Companies, Academic Research Centers and Other End-Uses for the Years 2015, 2025 & 2030
  • TABLE 386: Saudi Arabia Recent Past, Current & Future Analysis for Enzyme Immunoassays by Specimen - Blood, Saliva, Urine and Other Specimens - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 387: Saudi Arabia Historic Review for Enzyme Immunoassays by Specimen - Blood, Saliva, Urine and Other Specimens Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 388: Saudi Arabia 15-Year Perspective for Enzyme Immunoassays by Specimen - Percentage Breakdown of Value Sales for Blood, Saliva, Urine and Other Specimens for the Years 2015, 2025 & 2030
• UNITED ARAB EMIRATES
  • TABLE 389: UAE Recent Past, Current & Future Analysis for Enzyme Immunoassays by Product - Reagents & Kits, Analyzers / Instruments and Software & Services - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 390: UAE Historic Review for Enzyme Immunoassays by Product - Reagents & Kits, Analyzers / Instruments and Software & Services Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 391: UAE 15-Year Perspective for Enzyme Immunoassays by Product - Percentage Breakdown of Value Sales for Reagents & Kits, Analyzers / Instruments and Software & Services for the Years 2015, 2025 & 2030
  • TABLE 392: UAE Recent Past, Current & Future Analysis for Enzyme Immunoassays by Application - Cardiology, Endocrinology, Infectious Disease Testing, Autoimmune Diseases, Other Applications, Therapeutic Drug Monitoring and Oncology - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 393: UAE Historic Review for Enzyme Immunoassays by Application - Cardiology, Endocrinology, Infectious Disease Testing, Autoimmune Diseases, Other Applications, Therapeutic Drug Monitoring and Oncology Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 394: UAE 15-Year Perspective for Enzyme Immunoassays by Application - Percentage Breakdown of Value Sales for Cardiology, Endocrinology, Infectious Disease Testing, Autoimmune Diseases, Other Applications, Therapeutic Drug Monitoring and Oncology for the Years 2015, 2025 & 2030
  • TABLE 395: UAE Recent Past, Current & Future Analysis for Enzyme Immunoassays by End-Use - Hospitals, Blood Banks, Clinical Laboratories, Pharma & Biotech Companies, Academic Research Centers and Other End-Uses - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 396: UAE Historic Review for Enzyme Immunoassays by End-Use - Hospitals, Blood Banks, Clinical Laboratories, Pharma & Biotech Companies, Academic Research Centers and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 397: UAE 15-Year Perspective for Enzyme Immunoassays by End-Use - Percentage Breakdown of Value Sales for Hospitals, Blood Banks, Clinical Laboratories, Pharma & Biotech Companies, Academic Research Centers and Other End-Uses for the Years 2015, 2025 & 2030
  • TABLE 398: UAE Recent Past, Current & Future Analysis for Enzyme Immunoassays by Specimen - Blood, Saliva, Urine and Other Specimens - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 399: UAE Historic Review for Enzyme Immunoassays by Specimen - Blood, Saliva, Urine and Other Specimens Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 400: UAE 15-Year Perspective for Enzyme Immunoassays by Specimen - Percentage Breakdown of Value Sales for Blood, Saliva, Urine and Other Specimens for the Years 2015, 2025 & 2030
• REST OF MIDDLE EAST
  • TABLE 401: Rest of Middle East Recent Past, Current & Future Analysis for Enzyme Immunoassays by Product - Reagents & Kits, Analyzers / Instruments and Software & Services - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 402: Rest of Middle East Historic Review for Enzyme Immunoassays by Product - Reagents & Kits, Analyzers / Instruments and Software & Services Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 403: Rest of Middle East 15-Year Perspective for Enzyme Immunoassays by Product - Percentage Breakdown of Value Sales for Reagents & Kits, Analyzers / Instruments and Software & Services for the Years 2015, 2025 & 2030
  • TABLE 404: Rest of Middle East Recent Past, Current & Future Analysis for Enzyme Immunoassays by Application - Cardiology, Endocrinology, Infectious Disease Testing, Autoimmune Diseases, Other Applications, Therapeutic Drug Monitoring and Oncology - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 405: Rest of Middle East Historic Review for Enzyme Immunoassays by Application - Cardiology, Endocrinology, Infectious Disease Testing, Autoimmune Diseases, Other Applications, Therapeutic Drug Monitoring and Oncology Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 406: Rest of Middle East 15-Year Perspective for Enzyme Immunoassays by Application - Percentage Breakdown of Value Sales for Cardiology, Endocrinology, Infectious Disease Testing, Autoimmune Diseases, Other Applications, Therapeutic Drug Monitoring and Oncology for the Years 2015, 2025 & 2030
  • TABLE 407: Rest of Middle East Recent Past, Current & Future Analysis for Enzyme Immunoassays by End-Use - Hospitals, Blood Banks, Clinical Laboratories, Pharma & Biotech Companies, Academic Research Centers and Other End-Uses - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 408: Rest of Middle East Historic Review for Enzyme Immunoassays by End-Use - Hospitals, Blood Banks, Clinical Laboratories, Pharma & Biotech Companies, Academic Research Centers and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 409: Rest of Middle East 15-Year Perspective for Enzyme Immunoassays by End-Use - Percentage Breakdown of Value Sales for Hospitals, Blood Banks, Clinical Laboratories, Pharma & Biotech Companies, Academic Research Centers and Other End-Uses for the Years 2015, 2025 & 2030
  • TABLE 410: Rest of Middle East Recent Past, Current & Future Analysis for Enzyme Immunoassays by Specimen - Blood, Saliva, Urine and Other Specimens - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 411: Rest of Middle East Historic Review for Enzyme Immunoassays by Specimen - Blood, Saliva, Urine and Other Specimens Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 412: Rest of Middle East 15-Year Perspective for Enzyme Immunoassays by Specimen - Percentage Breakdown of Value Sales for Blood, Saliva, Urine and Other Specimens for the Years 2015, 2025 & 2030
• AFRICA
  • Enzyme Immunoassays Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Africa for 2025 (E)
  • TABLE 413: Africa Recent Past, Current & Future Analysis for Enzyme Immunoassays by Product - Reagents & Kits, Analyzers / Instruments and Software & Services - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 414: Africa Historic Review for Enzyme Immunoassays by Product - Reagents & Kits, Analyzers / Instruments and Software & Services Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 415: Africa 15-Year Perspective for Enzyme Immunoassays by Product - Percentage Breakdown of Value Sales for Reagents & Kits, Analyzers / Instruments and Software & Services for the Years 2015, 2025 & 2030
  • TABLE 416: Africa Recent Past, Current & Future Analysis for Enzyme Immunoassays by Application - Cardiology, Endocrinology, Infectious Disease Testing, Autoimmune Diseases, Other Applications, Therapeutic Drug Monitoring and Oncology - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 417: Africa Historic Review for Enzyme Immunoassays by Application - Cardiology, Endocrinology, Infectious Disease Testing, Autoimmune Diseases, Other Applications, Therapeutic Drug Monitoring and Oncology Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 418: Africa 15-Year Perspective for Enzyme Immunoassays by Application - Percentage Breakdown of Value Sales for Cardiology, Endocrinology, Infectious Disease Testing, Autoimmune Diseases, Other Applications, Therapeutic Drug Monitoring and Oncology for the Years 2015, 2025 & 2030
  • TABLE 419: Africa Recent Past, Current & Future Analysis for Enzyme Immunoassays by End-Use - Hospitals, Blood Banks, Clinical Laboratories, Pharma & Biotech Companies, Academic Research Centers and Other End-Uses - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 420: Africa Historic Review for Enzyme Immunoassays by End-Use - Hospitals, Blood Banks, Clinical Laboratories, Pharma & Biotech Companies, Academic Research Centers and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 421: Africa 15-Year Perspective for Enzyme Immunoassays by End-Use - Percentage Breakdown of Value Sales for Hospitals, Blood Banks, Clinical Laboratories, Pharma & Biotech Companies, Academic Research Centers and Other End-Uses for the Years 2015, 2025 & 2030
  • TABLE 422: Africa Recent Past, Current & Future Analysis for Enzyme Immunoassays by Specimen - Blood, Saliva, Urine and Other Specimens - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 423: Africa Historic Review for Enzyme Immunoassays by Specimen - Blood, Saliva, Urine and Other Specimens Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 424: Africa 15-Year Perspective for Enzyme Immunoassays by Specimen - Percentage Breakdown of Value Sales for Blood, Saliva, Urine and Other Specimens for the Years 2015, 2025 & 2030

IV. COMPETITION